BlackRock Health Science Term Trust (BMEZ) said Friday it launched a tender offer to acquire up to 40% of outstanding common shares.
Shares will be repurchased at a price equal to 99.5% of the fund's net asset value per share.
If more than 40% of the fund's shares are tendered, it will acquire them from tendering shareholders on a pro-rata basis.
The tender offer expires on April 17, and the pricing date is set for April 21.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。